发明名称 CHD Risk Stratification Evaluations for Subjects with High Levels of Large HDL-P
摘要 Embodiments of the invention are directed to methods, systems and computer programs that provide improved risk stratification for people having elevated large HDL-P using at least one defined HDL risk interaction parameter.
申请公布号 US2017017772(A1) 申请公布日期 2017.01.19
申请号 US201615280086 申请日期 2016.09.29
申请人 LipoScience, Inc. 发明人 OTVOS JAMES D.;SHALAUROVA IRINA Y.
分类号 G06F19/00;G01N33/487 主分类号 G06F19/00
代理机构 代理人
主权项 1. A method of determining whether a subject with elevated concentrations of very large high density lipoprotein (HDL) particles (HDL-P) is at increased risk for a cardiac event and/or CHD, comprising: programmatically calculating at least one HDL interaction risk parameter associated with HDL content of a blood plasma or serum sample of the subject, the at least one HDL interaction risk parameter comprising at least two of HPVS, HPML, and HPVL, where HPVS is a concentration of very small HDL-P subclasses, HPML is a concentration of medium and large HDL-P subclasses, and HPVL is a concentration of very large HDL-P subclasses.
地址 Raleigh NC US